Gluck, W. Larry; Gounder, Mrinal M.; Frank, Richard; Eskens, Ferry; Blay, Jean Yves; Cassier, Philippe A.; Soria, Jean Charles; Chawla, Sant; de Weger, Vincent; Wagner, Andrew J.; Siegel, David; De Vos, Filip; Rasmussen, Erik; Henary, Haby A.
(Kluwer Academic Publishers, 2020-06-01)
Background This open-label, first-in-human, phase 1 study evaluated AMG 232, an oral selective MDM2 inhibitor in patients with TP53 wild-type (P53WT), advanced solid tumors or multiple myeloma (MM). Methods In the dose ...